# SPI-1005 in Adults Receiving Cochlear Implant

> **NCT06340633** · PHASE2 · RECRUITING · sponsor: **Sound Pharmaceuticals, Incorporated** · enrollment: 40 (estimated)

## Conditions studied

- Hearing Loss
- Cochlear Trauma

## Interventions

- **DRUG:** Ebselen
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06340633
- **Lead sponsor:** Sound Pharmaceuticals, Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-08-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06340633

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06340633, "SPI-1005 in Adults Receiving Cochlear Implant". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06340633. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*